New research directions in neuroepidemiology

Epidemiologic Reviews

Volumn 22, Issue 1, 2000, Pages 18-23

  Cowan, Linda D ^a   Leviton, Alan ^b,c   Dammann, Olaf ^b,c  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CYTOKINE; THYROXINE;

ADULT; AGED; AGING; ALZHEIMER DISEASE; CENTRAL NERVOUS SYSTEM; CEREBRAL PALSY; CHILD; CONTROLLED STUDY; DISEASE PREDISPOSITION; GENETIC POLYMORPHISM; HUMAN; INFANT; INFLAMMATION; NEUROLOGIC DISEASE; NEWBORN; PREMATURITY; PRIORITY JOURNAL; REVIEW; RISK FACTOR; STROKE;

EID: 0033888912     PISSN: 0193936X     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.epirev.a018018     Document Type: Review

References (83)

1. The current neurologic burden of illness and injury in the United States
2. Neurological disorders
3. Neurological disorders
4. Neuroepidemiology
5. Epidemiology of Alzheimer's disease
6. Epidemiology of preterm birth
7. Prevention of premature birth
8. Outcomes of children of extremely low birth weight and gestational age in the 1990's
9. The inflammatory response system of brain: Implications for therapy of Alzheimer and other neurodegenerative diseases
10. Glial cytokines in Alzheimer's disease: Review and pathogenic implications
11. Inflammation and Alzheimer's disease: Mechanisms and therapeutic strategies
12. Mechanisms of tumor necrosis factor α action on neurodegeneration: Interaction with insulin-like growth factor-1
13. Maternal intrauterine infection, cytokines, and brain damage in the preterm newborn
14. Amniotic fluid inflammatory cytokines (IL-6, lL-beta, and TNF-alpha), neonatal brain white matter lesions, and cerebral palsy
15. Mechanisms of inflammation in MS tissue: Adhesion molecules and chemokines
16. Pathogenesis of tissue injury in MS lesions
17. Pathobiology of ischaemic stroke: An integrated view
18. Increased cytokine release from peripheral blood cells after acute stroke
19. Intrathecal release of pro- and anti-inflammatory cytokines during stroke
20. Neuroglial activation repertoire in the injured brain: Graded response, molecular mechanisms and cues to physiological function
21. Do chemokines mediate leukocyte recruitment in post-traumatic CNS inflammation?
22. The role of cytokines in the neuropathology of stroke and neurotrauma
23. Methodological issues for biomarkers and intermediate outcomes in cohort studies
24. Signaling events regulating the neurodevelopmental triad. Glutamate and secreted forms of beta-amyloid precursor protein as examples
25. Detection and measurement of cytokines
26. Cytokines and their receptors in the central nervous system: Physiology, pharmacology, and pathology
27. An introduction to the structure and function of inflammatory mediators for clinicians
28. Cytokines and the response to infection
29. Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome: What we do and do not know about cytokine regulation
30. Cytokines in the central nervous system: Regulatory roles in neuronal function, cell death and repair
31. Physiological and pathological roles of interleukin-6 in the central nervous system
32. Cytokines and the nervous system II: Actions and mechanisms of action
33. Cytokines and the nervous system I: Expression and recognition
34. Does the loss of placental hormones contribute to neurodevelopmental disabilities in preterm infants?
35. A novel role for thyroid hormone, glucocorticoids and retinoic acid in timing oligodendrocyte development
36. Programmed cell death and the control of cell survival: Lessons from the nervous system
37. Thyroid function in very preterm infants: Influences of gestational age and disease
38. Modification of the infection-associated risks of preterm birth and white matter damage in the preterm newborn by polymorphisms in the tumor necrosis factor-locus?
39. ApoE-4 and age at onset of Alzheimer's disease: The NIMH genetics initiative
40. Apolipoprotein E polymorphism in Alzheimer's disease: A comparative study of two research populations from Spain and the United States
41. Genetic epidemiology of Alzheimer disease
42. Assessing dementia. Part I. Difficulties, definitions and differential diagnosis
43. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
44. The clinical epidemiology of Alzheimer's disease
45. The prevalence of dementia is changing over time in Rochester, Minnesota
46. Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset
47. Familial aggregation of Alzheimer's disease and related disorders: A collaborative re-analysis of case-control studies
48. Occupational exposures to solvents and lead as risk factors for Alzheimer's disease: A collaborative re-analysis of case-control studies
49. Medical history and risk of Alzheimer's disease: A collaborative reanalysis of case-control studies
50. Estrogen replacement therapy and risk of Alzheimer disease
51. A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: The Baltimore Longitudinal Study of Aging
52. Postmenopausal estrogen replacement therapy and the risk of Alzheimer's disease: A population-based case-control study
53. The epidemiology of estrogen replacement therapy and Alzheimer's disease
54. The effect of estrogen replacement therapy on cognitive function in women: A critical review of the literature
55. Head trauma as a risk factor for Alzheimer's disease: A collaborative re-analysis of case-control studies
56. The association between head trauma and Alzheimer's disease
57. Head trauma and the risk of Alzheimer's disease
58. The occult aftermath of boxing
59. Alzheimer's disease: Pathology to potential treatments?
60. Cytokines in inflammatory brainlesions: Helpful and harmful
61. Risk of Alzheimer'sdisease and duration of NSAID use
62. The role of interleukin-1 in disease
63. White matter damage in preterm newbornsan epidemiological perspective
64. Periventricular leukomalacia: Risk factors revisited
65. Preterm birth and cerebral palsy: Is tumor necrosis factor the missing link?
66. Infection remote from the brain, neonatal white matter damage, and cerebral palsy in the preterm infant
67. Association between bacterial vaginosis and preterm delivery of a low-birthweight infant
68. Microbial invasion of the amniotic cavity during term labor. Prevalence and clinical significance
69. Detection of tumornecrosis factor-α, interleukin-6, and fetal fibronectin in the lower genital tract during pregnancy: Relation to outcome
70. Pathogenesis of preterm labor and preterm premature rupture of membranes associated with intraamniotic infection
71. Cytokines and preterm labor
72. A fetal systemic inflammatory response is followed by the spontaneous onset of preterm parturition
73. Intraamniotic inflammation and the development of cerebral palsy at three years of age
74. Obstetric antecedents of intraventricular hemorrhage and periventficular leukomalacia in the low-birthweight neonate
75. Neonatal cytokines and coagulation factors in children with cerebral palsy
76. Amniotic fluid infection and cerebral palsy. Focus on the fetus
77. Elevated placental cytokine release, a process associated with preterm labor in the absence of intrauterine infection
78. Hypothyroxinemia of prematurity and the risk of cerebral white matter damage
79. The relation of transient hypothyroxinemia in preterm infants to neurologic development at two years of age
80. Randomized study of the effect of antenatal dexamethasone on growth and development of premature children at the corrected age of 2 years